TrovaGene Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$8.49 |
Market Cap |
$13.06 M |
Shares Outstanding |
5.42 M |
Public Float |
3.99 M |
Address |
11055 Flintkote Avenue San Diego California 92121 United States |
Employees | - |
Website | http://www.trovagene.com |
Updated | 07/08/2019 |
Trovagene, Inc. is a clinical-stage, precision medicine oncology therapeutics company. Its focuses on developing PCM-075, is a Polo-like Kinase 1 (PLK1) selective adenosine triphosphate (ATP) competitive inhibitor. The company was founded by Gabriel M. |